Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
OXYTETRACYCLINE AS THE DIHYDRATE; FLUNIXIN AS FLUNIXIN MEGLUMINE
NORBROOK LABORATORIES AUSTRALIA PTY LIMITED
oxytetracycline as dihydrate(300mg/mL)+flunixin as meglumine(20mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
OXYTETRACYCLINE AS THE DIHYDRATE ANTIBIOTIC Active 300.0 mg/ml; FLUNIXIN AS FLUNIXIN MEGLUMINE BENZENE Active 20.0 mg/ml
100mL; 250mL; 500mL; 50mL
VM - Veterinary Medicine
CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER
ANTIBIOTIC & RELATED
BOVINE RESPIRATORY DISEASE | ORGANISMS SENSITIVE TO OXYTETRACYCLINE | ENTERIC BACTERIAL INFECTION | RESPIRATORY INFECTION | SHIPPING FEVER
Poison schedule: 4; Host/pest details: CATTLE: [BOVINE RESPIRATORY DISEASE, ORGANISMS SENSITIVE TO OXYTETRACYCLINE]; Poison schedule: 4; Withholding period: WHP: MEAT: DO NOT USE LESS THAN 28 DAYS BEFORE SLAUGHTER FOR HUMAN CONSUMPTION . MILK: DO NOT USE IN LACTATING COWS OR WITHIN 30 DAYS OF CALVING WHERE MILK OR MILK PRODUCTS MAY BE USED FOR HUMAN CONSUMPTION. SHOULD COWS CALVE EARLIER THAN 30 DAYS AFTER TREATMENT MILK COUL D CONTAIN RESIDUES. THIS MILK MUST NOT BE USED FOR HUMAN CONSUMPTION OR SUPPL IED FOR PROCESSING FOR AT LEAST 30 DAY S FOLLOWING TREATMENT. THIS MILK MUST N OT NE FED TO BOBBY CALVES DURING THIS T IME. EXPORT SLAUGHTER INTERVAL (ESI): D O NOT USE less than 28 days before slau ghter for export.; Host/pest details: CATTLE: [BOVINE RESPIRATORY DISEASE, ORGANISMS SENSITIVE TO OXYTETRACYCLINE]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE: [BOVINE RESPIRATORY DISEASE, ORGANISMS SENSITIVE TO OXYTETRACYCLINE]; For the treatment of bovine respiratory disease associated with pasteurellosis and other conditions in cattle caused by, or assoc. with, oxytet-sensitive organisms where an anti-inflammatory/anti-pyretic effect is required in the 24 hours post treatment.Restraints & Contra-Indications - Refer to product leaflet
Registered
2023-07-01
1W OSZ :s~ua~uo:> (8U !W nJ6aw U! X! unu se) NIXINn1.:11W/6W OZ pue (a}eJp .C A03W3H 1\fWIN'I NOildiH:lS3Hd PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN F OR ANIMAL TREATMENT ONLY HEXASOL LA (Oxytetracycline/Flunixin) Injection for Cattle 300 mg/ml OXYTETRACYCLINE (a s oxytetracy cli ne dihyd ra t e) and 20 mg/mL FL UNIXIN (as flunixin megluminel For the treatment of bov i ne respiratory disease associated with _Mannheimia _ _haemolytic _ _a _ (Pasteure llo sis), where an anti-inflammatory and anti-pyretic effect is req u ired in the 24 ho u rs post treatment For treatment of con d itions caused by, or assoc i ated with, or ganis ms sensitive to oxytetracycline in cattle where bo th an anti-inf lammatory and anti-pyretic effect is required in the 24 ho ur s post treatment Contents: 250 ml NorbrooJi ~ File Name: Dimensions: Scale: Date: READ Tl!E ENCLOSED LEAFI.ET BEFORE USING T111S PRODUCT DIRECTIONS FOR USE Restraints: DO NOT USE in lactating cows or within 30 days of calving wflere milk or milk products may be used for human consumption . Treated animals must be clearly identified in such a way that they will maintain their identity during the withholding period . Precautions : Use in any animals less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided,anunals may requ i re a reduced dosage a. nd careful clinical management This product does not contain an antimicrobial8rnervative . Swab the aeptwn before removing each dose. se a aterile neadle and syringe. Avoid administration of other NSAIDs concurrently or within 24 hours of this product. Concurrent use of potentially nephrotoxic drugs should be avoided. The stated doae or duration of treatment should not be exceeded. The use of tetracyclines during the period of tooth and bone development, including late pregnanc Read the complete document
PRODUCT NAME: HEXASOL LA (OXYTETRACYCLINE/FLUNIXIN) INJECTION FOR CATTLE PAGE: 1 OF 4 THIS REVISION ISSUED: JULY, 2009 MATERIAL SAFETY DATA SHEET Issued by: Norbrook Laboratories Australia Pty Ltd Freecall: 1800 665 866 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY NORBROOK LABORATORIES AUSTRALIA PTY LTD FREECALL: 1800 665 866 UNIT 7/1 TRADE PARK DRIVE TULLAMARINE, VIC 3043 AUSTRALIA SUBSTANCE: Oxytetracycline is an antibiotic. TRADE NAME: HEXASOL LA (OXYTETRACYCLINE/FLUNIXIN) INJECTION FOR CATTLE PRODUCT USE: Anti-bacterial/anti-inflammatory for the treatment of a wide range of infections caused by oxytetracycline susceptible organisms. CREATION DATE: JULY, 2009 THIS VERSION ISSUED: JULY, 2009 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: T, Toxic. Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: R25. Toxic if swallowed. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR : Clear, dark amber solution. ODOUR: No odour. MAJOR HEALTH HAZARDS: toxic if swallowed. This is an antibiotic preparation. Any person with a history of allergies to this class of substances should avoid all contact with this product as it may cause sensitisation. This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can sometimes give unexpected and undesired results. POTENTIAL HEALTH EFFECTS INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data fo Read the complete document